Nexus BioQuest

Nexus BioQuest is a specialized immunology Contract Research Organisation (CRO) based in London, serving biotech and pharma clients in the immune-therapeutics space. The company offers bespoke assay design, target validation, mechanistic studies, and translational research services, focusing on immuno-oncology, autoimmunity, neuroinflammation, and general inflammation. Founded on values of curiosity, collaboration, and integrity, it positions itself as a collaborative scientific partner rather than just a service provider, aiming to accelerate clients' programs from concept to clinic.

Integrated immunology-focused service platform offering bespoke assay design, validated preclinical and non-regulatory clinical assays, and deep therapeutic area expertise in immune-oncology, autoimmunity, and inflammation. Leverages standard lab technologies applied through deep immunological knowledge to generate actionable data for drug discovery clients.

Nexus BioQuest competes in the fragmented preclinical CRO market. It faces competition from large, full-service global CROs (e.g., LabCorp, Charles River) and other niche, immunology-focused service providers. Its differentiation is its deep therapeutic area specialization, bespoke/collaborative service model, and focus on complex immunological questions, rather than high-volume, standardized testing.